Benefits and Pitfalls of Prostate Cancer Screening: 'No Proof of Benefit' Does Not Equal 'Proof of No Benefit'.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Works matching IS 08909091 AND DT 2011 AND VI 25 AND IP 6
Results: 21
1
2
Shiitake mushroom (Lentinula edodes)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
3
The Discussions Continue.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
4
ERRATA.
- Published in:
- 2011
- Publication type:
- Correction Notice
5
Shiitake mushroom (Lentinula edodes).
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 548
- By:
- Publication type:
- Article
6
First-in-Class Antimitotic Device Approved for Glioblastoma.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 546
- Publication type:
- Article
7
Aggressive Prostate Cancer: High Blood Levels of Omega-3s Doubled the Risk, but High Levels of Trans-Fatty Acids Cut Risk in Half.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 544
- Publication type:
- Article
8
Link Found Between Inflammation and Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 544
- Publication type:
- Article
9
The IGF-1R Pathway as a Therapeutic Target.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 538
- By:
- Publication type:
- Article
10
Targeting IGF-1R: at a Crossroad.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 535
- By:
- Publication type:
- Article
11
Targeting the Insulin Growth Factor Pathway in Gastrointestinal Cancers.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 518
- By:
- Publication type:
- Article
12
Evolving Therapeutic Paradigms for Advanced Prostate Cancer: What's Needed to Make Optimal Use of the New Treatments.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 514
- By:
- Publication type:
- Article
13
Advanced Prostate Cancer: New Agents, New Questions.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 509
- By:
- Publication type:
- Article
14
Evolving Therapeutic Paradigms for Advanced Prostate Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 496
- By:
- Publication type:
- Article
15
Myelodysplastic Syndromes: Where Do We Go From Here?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 492
- By:
- Publication type:
- Article
16
Tricking or Treating Myelodysplastic Syndromes.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 488
- By:
- Publication type:
- Article
17
When to Treat Myelodysplastic Syndromes.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 480
- By:
- Publication type:
- Article
18
Preventing Prostate Cancer Overdiagnosis From Becoming Overtreatment.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 468
- By:
- Publication type:
- Article
19
Benefits and Pitfalls of Prostate Cancer Screening: "No Proof of Benefit" Does Not Equal "Proof of No Benefit"
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 466
- By:
- Publication type:
- Article
20
Screening for Prostate Cancer With PSA Testing: Current Status and Future Directions.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 452
- By:
- Publication type:
- Article
21
Oncology Care in 2021: the FDA, Medicare, and Healthcare Reform.
- Published in:
- 2011
- Publication type:
- Interview